← Russell 3000 cross-section

MTD METTLER TOLEDO INTERNATIONAL INC/

Trailing twelve months to 2026-06-30 · as filed 2026-07-31, not restated
Healthcare

Scale

Market cap
$28.6bn
Revenue TTM
$4.1bn
Net income TTM
$906m
Free cash flow
$864m
Composite score
Sector rank
#346

Valuation

P / E
31.6
EV / EBITDA
EV / sales
7.4
FCF yield
3.02%
Earnings yield vs 10-yr
-1.57pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
21.9%
EBITDA margin
ROE
7,062.4%
ROIC
Revenue growth
6.9%

Insider activity, last 90 days

Net open-market
$-4.75m
Buyers
0
Sellers
3

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Net sales Net sales were $1.0 billion and $983.2 million for the three months ended June 30, 2026, and 2025, respectively, and $2.0 billion and $1.9 billion for the six months ended June 30, 2026, and 2025, respectively. Sales in U.S. dollars increased 4% for the three months and increased 6% for the six months ended June 30, 2026, respectively. Excluding the effect of currency exchange fluctuations, or in local currencies, net sales increased 6% for the three months and 4% for the six months ended June 30, 2026, respectively, before the previously described one-time tariff-related customer refunds. …METTLER TOLEDO INTERNATIONAL INC/, 10-Q, period ended 2026-06-30, filed 2026-07-31

Read the full passage →